Precision BioSciences, Inc.
DTIL
Positions held
Your positionsDTIL isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $177.48M | Enterprise value | $118.03M | Trailing P/E | — | Forward P/E | -3.46 |
| PEG | — | Price / book | 3.75 | Beta | 1.28 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 100.0% | Operating margin | -80.8% |
| Profit margin | -117.0% | ROE | -135.1% | ROA | -19.4% | Debt / equity | 0.62 |
| Current ratio | 12.82 | Free cash flow | -$16.25M | Analyst recommendation | none | Mean target | $29.40 |
| 52w high | $9.62 | 52w low | $3.53 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $10.8M | $34.2M | $0.0M | $0.0M | — |
| Op margin | — | -83.7% | 36.6% | -158976.9% | -121538.9% | — |
| Net income | -$32.7M | -$18.4M | $20.1M | -$21.8M | -$23.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$19.2M | -$9.1M | $12.5M | -$20.7M | -$21.9M | — |
- Revenue -100% vs prior quarter ($0 vs $11M).
- Operating margin compressed to -83.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $34.3M | $68.7M | $48.7M | $25.1M | — |
| Op margin | -152.2% | -38.1% | -89.8% | -248.3% | — |
| Net income | -$45.7M | $7.2M | -$61.3M | -$112M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$52.1M | -$26.2M | -$43.7M | -$62.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
2026-09-17 · Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
2026-08-24 · Precision BioSciences Doses First Patient in Trial of Potential Duchenne Muscular Dystrophy Treatment
2026-08-24 · Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
2026-08-06 · Precision BioSciences: Q2 Earnings Snapshot
2026-08-06 · Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-07-31 · Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
Price (daily)
Full chart · RSI · MACD · patterns